CityA.M.

MGC Pharmaceuticals (LON: MXC), a publicly-traded cannabis company, recently finalized pre-clinical trial research of cannabinoids as a potential treatment for glioblastoma, an aggressive brain cancer. The results were positive, reported CityA.M. The European-...